Montagu Private Equity announced on January 14 the acquisition of Tyber Medical for an undisclosed price. With this transaction, Montagu will merge Tyber Medical with its portfolio companies Intech and Resolve Surgical Technologies to create a new platform.
Tyber Medical is an orthopedic medical device manufacturer providing rapid access to FDA-cleared and CE-marked private label, regulatory-approved orthopedic implants for the spinal, extremity and trauma markets. Since it was founded in 2012, the company has released more than 50 spine, extremity and trauma systems.
Montagu Private Equity is one of Europe’s leading private equity firms, with assets under management of approximately $4.79 billion. Montagu partners with companies with enterprise values between $222 million and $1.1 billion and has made more than 400 investments over the last fifty years.
Houlihan Lokey served as Tyber Medical’s exclusive financial advisor, while Dechert LLP acted as its legal advisor. Weil Gotshal & Manges acted as legal advisor to Montagu, Intech and Resolve.
According to data in the LevinPro HC database, this merger marks the sixth Medical Devices transaction of 2025. Throughout 2024, there were 88 Medical Devices acquisitions announced. This is also Montagu Private Equity’s first acquisition of the year.
